Riboflavin opthalmic - Epion Therapeutics
Alternative Names: EpiSmart™; Ribostat™Latest Information Update: 02 Nov 2023
At a glance
- Originator CXL Ophthalmics
- Developer Epion Therapeutics
- Class Antimigraines; Eye disorder therapies; Flavins; Small molecules; Vitamins
- Mechanism of Action Photosensitisers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Keratoconus